Medicus Pharma Ltd (TSE:MDCX) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Medicus Pharma Ltd has successfully closed its $4 million initial public offering in the U.S., with its shares and warrants now trading on Nasdaq. The company plans to use the proceeds to advance its clinical trials for treating basal cell carcinoma and explore other non-melanoma skin diseases. Maxim Group LLC and Brookline Capital Markets managed the offering, with the underwriter partially exercising its overallotment option.
For further insights into TSE:MDCX stock, check out TipRanks’ Stock Analysis page.
